Learning Hub Central

Lymphoma

2022 NOSCM | Waldenstrom’s Macroglobulinemia

2022 NOSCM | Waldenstrom’s Macroglobulinemia

Lymphoma

1 Chapter

Non-CME Credit Course

Updates in Treatment of Lymphoma

Updates in Treatment of Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

2021 AIO | Optimal Therapeutic Strategies for non-Hodgkin lymphoma

2021 AIO | Optimal Therapeutic Strategies for non-Hodgkin lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

2021 UCT | Update from ASCO/AACR/ESMO in T-cell NHL

2021 UCT | Update from ASCO/AACR/ESMO in T-cell NHL

Lymphoma

1 Chapter

Non-CME Credit Course

T-Cell NHL: What’s New?

T-Cell NHL: What’s New?

Lymphoma

1 Chapter

Non-CME Credit Course

2021 NOSCM | Follicular Lymphoma: Novel Advances and Pathways

2021 NOSCM | Follicular Lymphoma: Novel Advances and Pathways

Lymphoma

1 Chapter

Non-CME Credit Course

2022 AIO | Lymphoma Data Science from Populations to Precision Medicine and Back

2022 AIO | Lymphoma Data Science from Populations to Precision Medicine and Back

Lymphoma

1 Chapter

Non-CME Credit Course

2022 AIO | Large B-cell Lymphoma: What to do now and what’s coming next

2022 AIO | Large B-cell Lymphoma: What to do now and what’s coming next

Lymphoma

1 Chapter

Non-CME Credit Course

2022 MCM | B-Cell Lymphomas: Updates and Future Directions

2022 MCM | B-Cell Lymphomas: Updates and Future Directions

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | DLBCL & Hodgkin’s Disease: Novel Approaches

2022 NOSCM | DLBCL & Hodgkin’s Disease: Novel Approaches

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | New Approaches for Follicular Lymphoma

2022 NOSCM | New Approaches for Follicular Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

2022 NOSCM | CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

Lymphoma

1 Chapter

Non-CME Credit Course

Follicular Lymphoma and CLL Updates 2023

Follicular Lymphoma and CLL Updates 2023

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | T-Cell NHL: Novel Approaches & Challenges

2022 NOSCM | T-Cell NHL: Novel Approaches & Challenges

Lymphoma

1 Chapter

Non-CME Credit Course

2022 CCC | Lymphoma: State of the Art

2022 CCC | Lymphoma: State of the Art

Lymphoma

1 Chapter

Non-CME Credit Course

2022 UCT | Update on T-cell Lymphomas

2022 UCT | Update on T-cell Lymphomas

Lymphoma

1 Chapter

Non-CME Credit Course

2022 UCT | Modern Challenges and new options for B-cell NHL

2022 UCT | Modern Challenges and new options for B-cell NHL

Lymphoma

1 Chapter

Non-CME Credit Course

2024 PRIMO | Update on Novel Therapies for NHL

2024 PRIMO | Update on Novel Therapies for NHL

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MCM | B-Cell NHL (Low-Grades)

2024 MCM | B-Cell NHL (Low-Grades)

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MLS Nashville | CLL/Lymphoma Updates in 2024

2024 MLS Nashville | CLL/Lymphoma Updates in 2024

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | What Is New for DLBCL and & Hodgkin’s Disease?

2024 NOSCM | What Is New for DLBCL and & Hodgkin’s Disease?

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | Novel Advances in T-Cell NHL Therapies

2024 NOSCM | Novel Advances in T-Cell NHL Therapies

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

2024 NOSCM | Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | CAR-T Cell Therapy in Lymphomas: 7-Years Later

2024 NOSCM | CAR-T Cell Therapy in Lymphomas: 7-Years Later

Lymphoma

1 Chapter

Non-CME Credit Course

2022 AIO | State of the Art in non-Hodgkin lymphoma

2022 AIO | State of the Art in non-Hodgkin lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MCM | T-Cell NHL- Novel Therapies

2024 MCM | T-Cell NHL- Novel Therapies

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MCM | B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?)

2024 MCM | B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?)

Lymphoma

1 Chapter

Non-CME Credit Course

MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo